A Meta-Analysis of Efficacy and Safety of Infliximab for Prevention of Postoperative Recurrence in Patients with Crohn’s Disease

Figure 3

Risk of bias assessment. The qualities of the included studies were evaluated using Cochrane collaboration tool, indicating that there is no significant risk of bias in the included trials of this meta-analysis.